These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals. Ramírez E; Jiménez C; Borobia AM; Tong HY; Medrano N; Krauel-Bidwell L; Carcas AJ; Selgas R; Frías J Ther Drug Monit; 2013 Jun; 35(3):360-6. PubMed ID: 23666575 [TBL] [Abstract][Full Text] [Related]
4. Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam. Holsen MR; Meaney CJ; Hassinger AB; Fusco NM Pediatr Crit Care Med; 2017 Dec; 18(12):e585-e591. PubMed ID: 28906422 [TBL] [Abstract][Full Text] [Related]
5. Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Zappitelli M; Moffett BS; Hyder A; Goldstein SL Nephrol Dial Transplant; 2011 Jan; 26(1):144-50. PubMed ID: 20591815 [TBL] [Abstract][Full Text] [Related]
6. Drug use density in critically ill children and newborns: analysis of various methodologies. Valcourt K; Norozian F; Lee H; Raszynski A; Torbati D; Totapally BR Pediatr Crit Care Med; 2009 Jul; 10(4):495-9. PubMed ID: 19451853 [TBL] [Abstract][Full Text] [Related]
7. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children. Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124 [TBL] [Abstract][Full Text] [Related]
8. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study. Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639 [TBL] [Abstract][Full Text] [Related]
9. Supratherapeutic vancomycin levels after trauma predict acute kidney injury and mortality. Ley EJ; Liou DZ; Singer MB; Mirocha J; Srour M; Bukur M; Margulies DR; Salim A J Surg Res; 2013 Sep; 184(1):501-6. PubMed ID: 23731689 [TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit. Cies JJ; Shankar V Pharmacotherapy; 2013 Apr; 33(4):392-400. PubMed ID: 23471688 [TBL] [Abstract][Full Text] [Related]
11. Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation. Slater MB; Gruneir A; Rochon PA; Howard AW; Koren G; Parshuram CS Paediatr Drugs; 2017 Feb; 19(1):59-67. PubMed ID: 27943125 [TBL] [Abstract][Full Text] [Related]
12. Factors associated with acute kidney injury in children receiving vancomycin. Sinclair EA; Yenokyan G; McMunn A; Fadrowski JJ; Milstone AM; Lee CK Ann Pharmacother; 2014 Dec; 48(12):1555-62. PubMed ID: 25186624 [TBL] [Abstract][Full Text] [Related]
13. Vancomycin-associated acute kidney injury: A cross-sectional study from a single center in China. Pan K; Ma L; Xiang Q; Li X; Li H; Zhou Y; Yang L; Cui Y PLoS One; 2017; 12(4):e0175688. PubMed ID: 28426688 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of acute kidney injury in Canadian critical care units: a prospective cohort study. Odutayo A; Adhikari NK; Barton J; Burns KE; Friedrich JO; Klein D; Lapinsky S; Litwin S; Meret A; Moineddin R; Richardson B; Richardson R; Zaltzman A; Hladunewich M; Wald R Can J Anaesth; 2012 Oct; 59(10):934-42. PubMed ID: 22843289 [TBL] [Abstract][Full Text] [Related]
15. Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit. Schneider J; Khemani R; Grushkin C; Bart R Crit Care Med; 2010 Mar; 38(3):933-9. PubMed ID: 20124891 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors for acute kidney injury associated with parenteral polymyxin B use. Mendes CA; Cordeiro JA; Burdmann EA Ann Pharmacother; 2009 Dec; 43(12):1948-55. PubMed ID: 19887593 [TBL] [Abstract][Full Text] [Related]
17. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem. Robertson AD; Li C; Hammond DA; Dickey TA Pharmacotherapy; 2018 Dec; 38(12):1184-1193. PubMed ID: 30175410 [TBL] [Abstract][Full Text] [Related]
18. Addition of Vancomycin to Cefazolin Prophylaxis Is Associated With Acute Kidney Injury After Primary Joint Arthroplasty. Courtney PM; Melnic CM; Zimmer Z; Anari J; Lee GC Clin Orthop Relat Res; 2015 Jul; 473(7):2197-203. PubMed ID: 25421958 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium. Tuon FF; Rigatto MH; Lopes CK; Kamei LK; Rocha JL; Zavascki AP Int J Antimicrob Agents; 2014 Apr; 43(4):349-52. PubMed ID: 24439066 [TBL] [Abstract][Full Text] [Related]